Dr. David A. Scheinberg, MD, PhD, is a world-leading physician–scientist in leukemia immunotherapy who holds the Vincent Astor Chair and serves as Chair of the Center for Experimental Therapeutics and Deputy Director for Therapeutic Discovery at the Sloan Kettering Institute of Memorial Sloan Kettering Cancer Center. He earned his MD and PhD from Johns Hopkins School of Medicine in 1983 and completed internal medicine residency at The New York Hospital–Cornell Medical Center, followed by fellowship training at MSKCC. Board-certified in Internal Medicine and Medical Oncology, Dr. Scheinberg provides clinical care for patients with leukemia and directs laboratory research aimed at developing novel targeted immunotherapies, including monoclonal antibodies, T-cell receptor mimic antibodies, targeted nanodevices, cellular “micropharmacies,” and therapeutic cancer vaccines.
Why they are a top doctor
Research papers · PubMed
173
Published, peer-reviewed work, the clearest public measure of expertise in a specialty.
Cited by other doctors
26.7k
How often other doctors and researchers build on their work.
Known for
Immunotherapy and cancer vaccines
The distinction that sets them apart from other leukemia specialist & Physician-Scientists.
Specializes in
Drug development
A narrow focus means they see far more of these cases than a general oncologist.
Background
Education
Medical school: The Johns Hopkins School of Medicine
Residency: The New York Hospital/Cornell Medical Center
Fellowships: Memorial Sloan Kettering Cancer Center
Board certifications: Internal Medicine · Medical Oncology
Awards
National Cancer Institute Outstanding Investigator Award (OIA)
Elected Member, Association of American Physicians